Pediatrix Medical (MD) Change in Receivables (2009 - 2026)

Pediatrix Medical has disclosed Change in Receivables across 18 years of filings, most recently posting -$4.9 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 72.14% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$18.0 million (up 52.34% YoY), while the FY2025 annual figure was -$30.6 million, down 196.91% from the prior year.
• Change in Receivables declined to -$4.9 million in Q1 2026, from -$1.5 million in the prior quarter.
• Over the last five years, Change in Receivables for MD reached as high as $20.2 million in Q1 2022 and fell as low as -$21.3 million in Q1 2023.
• The 5-year median for Change in Receivables is -$4.2 million (2022), against an average of -$3.9 million.
• Annual changes were most pronounced in 2024 — Change in Receivables jumped 146.55% — and 2025, when it sank 401.59%.
• A 5-year view of Change in Receivables shows it stood at $5.0 million in 2022, then tumbled by 182.92% to -$4.2 million in 2023, then plunged by 130.97% to -$9.7 million in 2024, then surged by 84.91% to -$1.5 million in 2025, then plunged by 233.84% to -$4.9 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$4.9 million, -$1.5 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.